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The OdhI protein is key regulator of the TCA cycle in
Corynebacterium glutamicum. This highly conserved
protein is found in GC rich Gram-positive bacteria
(e.g., the pathogenic Mycobacterium tuberculosis).
The unphosphorylated form of OdhI inhibits the
OdhA protein, a key enzyme of the TCA cycle,
whereas the phosphorylated form is inactive. OdhI is
predicted to bemainly a single FHAdomain, amodule
that mediates protein-protein interaction through
binding of phosphothreonine peptides, with a disor-
dered N-terminal extension substrate of the serine/
threonine protein kinases. In this study, we solved
the solution structure of the unphosphorylated and
phosphorylated isoforms of the protein.We observed
a major conformational change between the two
forms characterized by the binding of the phosphory-
lated N-terminal part of the protein to its own FHA
domain, consequently inhibiting it. This structural
observation corresponds to a new autoinhibition
mechanism described for a FHA domain protein.
INTRODUCTION
Reversible protein phosphorylation is a keymechanism bywhich
environmental signals are transmitted to modify protein expres-
sion or activity in eukaryotes and prokaryotes, and therefore
represents a crucial mechanism by which exogenous signals
are translated into cellular responses. Eukaryotic-like Ser/Thr
protein kinases (STPKs) present in bacteria are thought to play
important functions in cell signaling responses as well as in
essential metabolic pathways. However, understanding
prokaryotic kinase biology has been hampered by the failure to
identify relevant kinase substrates and subsequently charac-568 Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All righterize the phosphorylation site(s). In addition, very little is known
about how phosphorylation induces structural modifications in
STPK substrates, ultimately leading to changes in the biological
responses in bacteria.
Corynebacterium glutamicum is a nonpathogenic Gram-posi-
tive bacterium used for industrial production of L-glutamate and
other amino acids (Kimura, 2003) and represents a valuable
model organism to study Corynebacteriaceae, a suborder of
actinomycetes that includes Mycobacterium (Alderwick et al.,
2005). Recent studies have brought to light an unusual post-
translational regulation mechanism of the tricarboxylic (TCA)
cycle in C. glutamicum (Bott, 2007). In this organism, the
450 kDa 2-oxoglutarate dehydrogenase multienzyme complex
(ODHC) catalyzes the fourth step of the TCA cycle, and regula-
tion of ODHC activity was shown to be dependent on the OdhI
(for ODHC inhibitor) phosphorylation status. In fact, the unphos-
phorylated form of OdhI binds with high-affinity to OdhA, the
putative E1 subunit of the ODHC complex, thus inhibiting its
activity, whereas OdhI phosphorylation relieves this inhibition
(Niebisch et al., 2006). Regulation of the TCA cycle by phosphor-
ylation of the isocitrate deshydrogenase has been reported in
enteric bacteria (Cozzone, 1998). The channeling of isocitrate
through the glyoxylate bypass is regulated via direct phosphor-
ylation/dephosphorylation of the isocitrate dehydrogenase, the
enzyme of the TCA cycle. However, in the present study, we
characterize for the first time a novel way of controlling the
TCA cycle via the 2-oxoglutarate dehydrogenase, which is not
directly phosphorylated but regulated via a phosphorylation/
dephosphorylation mechanism of its specific binding regulator,
OdhI.
C. glutamicum contains four STPKs namedCgPknA, CgPknB,
CgPknG, and CgPknL (Kalinowski et al., 2003). Inactivation of
CgpknL or CgpknG in C. glutamicum resulted in viable mutants
with a normal cell morphology or growth rate. In sharp contrast,
CgpknA and CgpknB were found to be essential (Fiuza et al.,
2008). Partial deletion of CgPknA or CgPknB in conditional
mutants resulted in elongated cells, leading to the conclusionts reserved
Structure
Solution Structure of OdhIthat these two kinases are key players in signal transduction
pathways controlling corynebacterial cell shape and growth. In
addition, both CgPknA and CgPknB were able to phosphorylate
OdhI in vitro (Fiuza et al., 2008), while OdhI was originally re-
ported to be a substrate of CgPknG (Niebisch et al., 2006).
OdhI is a 15 kDa protein, and structure prediction proposed
that it is almost solely composed of a forkhead-associated
(FHA) domain adjacent to an unfolded 40-residues N-terminal
extension where phosphorylation occurs (Niebisch et al.,
2006). FHA domains are modular recognition domains highly
specific to phosphothreonine and participating in various biolog-
ical processes such as transcription, DNA repair, or protein
degradation in eukaryotes (Durocher and Jackson, 2002). This
FHA-containing protein is highly conserved in actinomycetes,
suggesting that it plays an important role in the physiology of
these organisms. In M. tuberculosis, the OdhI ortholog named
GarA (Rv1827) shares 60% of sequence identity (82% for the
FHA domain) with OdhI and has been partially characterized
(Villarino et al., 2005). Like OdhI, GarA was found to be phos-
phorylated by mycobacterial STPKs on an N-terminal threonine
residue (Villarino et al., 2005). Conservation of OdhI with GarA,
and OdhA with its M. tuberculosis ortholog KGD (Rv1248c),
leads to the hypothesis of common functions and regulatory
mechanisms. Recent studies have unraveled a role for GarA in
regulation of glutamate metabolism and demonstrated that
bothM. tuberculosis PknB and PknGwere able to phosphorylate
GarA (O’Hare et al., 2008). Interestingly, M. tuberculosis PknG
phosphorylates GarA at Thr21, adjacent to the residue phos-
phorylated by PknB (T22), and that these two phosphorylation
events are mutually exclusive, supporting the occurrence of
a site-specific kinase-dependent mechanism.
Because in OdhI only Thr14 (the equivalent of Thr21 in GarA)
has been uncovered following phosphorylation with CgPknG,
we addressed whether the adjacent residue Thr15 (the equiva-
lent of Thr22 in GarA) could also represent a potential phosphor-
ylation site for CgPknA or CgPknB. We therefore identified the
phosphorylated site(s) of OdhI by mass spectrometry analysis
Figure 1. Multiple Sequence Alignment of
OdhI Ortholog Proteins from Corynebacte-
ria and Mycobacteria
Sequence alignment of the Corynebacterium
glutamicum OdhI homologs in Corynebacterium
diphtheriae, Mycobacterium tuberculosis, Myco-
bacterium ulcerans, Mycobacterium avium, and
Mycobacterium smegmatis. The conserved Thr
residues described inM. tuberculosis andC. gluta-
micum as the phosphorylation sites are highlighted
in green. Protein secondary element assignments
for the phosphorylated form of OdhI are repre-
sented on the top of the sequences. Numbering
of amino acids corresponds to the OdhI protein
from C. glutamicum.
following phosphorylation with either
CgPknA or CgPknB. Then, to decipher
the molecular mechanism responsible
for the release of the inhibition on OdhA
via OdhI, as well as the binding properties
of the OdhI regulator after phosphoryla-
tion, we determined the solution structures of both unphos-
phorylated (OdhI) and phosphorylated isoforms of OdhI (pOdhI)
usingmultidimensional nuclearmagnetic resonance (NMR) tech-
niques. Our study unraveled a new structural mechanism in
which the unstructured N-terminal segment of OdhI undergoes
considerable conformational changes upon phosphorylation by
CgPknA or CgPknB. These changes comprise a switch of the
N-terminal part of the protein in close vicinity to the FHA domain
phosphopeptide binding site. Herein, we describe an original
mechanism of autoinhibition of OdhI and provide a structural
model describing how phosphorylation of a single Thr residue
in a disordered domain affects the overall structure of a protein,
ultimately conditioning the regulation of a major metabolic
pathway.
RESULTS
C. glutamicum PknA/B Phosphorylate OdhI on Thr15
The OdhI/GarA family of proteins appears to be conserved in
actinomycetes, and close members of this family have been
found in Corynebacterium, Mycobacterium, Rhodococcus, and
Streptomyces. Figure 1 presents multiple sequence alignments
of OdhI proteins in several corynebacterial and mycobacterial
species, including pathogenic and nonpathogenic species.
C. glutamicum contains four STPKs named CgPknA, CgPknB,
CgPknG, and CgPknL (Kalinowski et al., 2003). It was previously
demonstrated that a C. glutamicum strain lacking a functional
CgPknG was impaired in glutamine utilization. Subsequent pro-
teome analysis led to the identification of OdhI, a 15 kDa protein,
as a substrate of CgPknG (Niebisch et al., 2006). Moreover,
CgPknG was shown to phosphorylate OdhI at position Thr14.
A recent study dedicated to characterize the four corynebacte-
rial STPKs reported that both CgPknA and CgPknB could effi-
ciently phosphorylate OdhI in vitro in addition to CgPknG (Fiuza
et al., 2008). This protein was found to be highly homologous to
the M. tuberculosis GarA protein (Villarino et al., 2005). Interest-
ingly, O’Hara et al. (2008) demonstrated that M. tuberculosisStructure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 569
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phosphorylated by PknB (Thr22), and that these two phosphor-
ylation events aremutually exclusive. These unexpected findings
brought us to investigate whether CgPknA and CgPknB phos-
phorylate OdhI on Thr14, like CgPknG, or on Thr15. To this
aim, a mass spectrometry technique was successfully devel-
oped to decipher the phosphorylation site(s). Purified recombi-
nant OdhI was incubated with ATP in the presence of CgPknA,
and subjected to mass spectrometry analysis after tryptic diges-
tion. ProteinPilot database-searching software (version 2.0,
Applied Biosystems), using the Paragon method with phosphor-
ylation emphasis, was used to detect and identify the phosphor-
ylated peptides. The sequence coverage of the protein was
99%, and MS/MS spectrum of the triply charged ion [M+3H]3+
at m/z 1059.8 of peptide [8–19] (monoisotopic mass:
3176.38 Da) unambiguously confirmed the location of the phos-
phate group on Thr15 as showed by observation of the ‘‘y’’
C-terminal daughter ion series (Figure 2). Moreover, similar MS
spectra were obtained when OdhI was phosphorylated with
CgPknB alone, or with a mix CgPknA/CgPknB (data not shown).
Overall, these results indicate that CgPknA or CgPknB phos-
phorylate OdhI on Thr15, which is adjacent to the residue phos-
phorylated by CgPknG (Thr14). This scenario is reminiscent of
what was reported for GarA in M. tuberculosis (O’Hare et al.,
2008) and supports the occurrence of a site-specific kinase-
dependent mechanism. Moreover, these results appear to
suggest that corynebacterial and mycobacterial kinases share
similar phosphorylation specificity toward their substrates OdhI
or GarA, and could therefore be regarded as genuine functional
orthologs.
NMR Structure of the Unphosphorylated Form of OdhI
[1H,15N] heteronuclear single-quantum coherence (HSQC) spec-
trum of OdhI is shown in Figure 3. By combining the information
from the double- and triple-resonance heteronuclear experi-
Figure 2. MS/MS Spectrum of the Triply
Charged Ion [M+3H]3+ at m/z 1059.8 of
Peptide [8–19] (Monoisotopic Mass:
3176.38 Da)
Unambiguous location of the phosphate group on
Thr15 was showed by observation of the ‘‘y’’
C-terminal daughter ion series. Starting from the
C-terminal residue, all ‘‘y’’ ions loose phosphoric
acid (98 Da) after the Thr15 phosphorylated
residue.
ments, we were able to assign all the
amide group resonances for the nonpro-
line residues (9 prolines), 99.8% of the
other backbone resonances (Ca, C0, and
Ha), more than 93.8% of the Cb reso-
nances, and 91% of the side chain
protons.
In agreement with our sequence anal-
ysis, NMR experiments revealed that the
N-terminal part of the unphosphorylated
OdhI protein is fully disordered (Met1-
Glu40). The corresponding residues give
rise to the intense cross-peaks centered at 8.5 ppm in the
HSQC spectrum. The rest of the molecule folds in a well-defined
FHA domain. The global fold of the FHA domain, a b sandwich
composed of 11 strands, is well conserved (Figure 4A) and
similar to what has been described for the structures of the
human Chk2 kinase or Ki67 FHA domains (rmsd of 1.62 A˚ and
1.68 A˚, respectively; Li et al., 2002, 2004). However, superimpo-
sition with other FHA domain structures in the free form or in
complex with a phosphopeptide revealed a particular conforma-
tion of the phosphopeptide-binding surface composed of loops
connecting the b strands, mainly the loops b3/b4, b4/b5, and b6/
b7. In the previously solved FHA domain containing protein
structures, the phosphopeptide-binding loops adopted the
same conformation in both free and complexed forms (i.e.,
PDB1R21 versus PDB2AFF; see Figure S1A available online).
Here, loop b6/b7 in the free form is at the position that would
be normally occupied by the pThr in the complexed form
(Figure S1B). Concomitantly, the b3/b4 loop adopts a conforma-
tion incompatible with the phosphopeptide binding, whereas the
position of loop b6/b7 is similar to that observed in related FHA
domain structures.
NMR Structure of the Phosphorylated Form
of OdhI (pOdhI)
High phosphorylation yields were obtained by incubating puri-
fied 15N-labeled OdhI with both purified C. glutamicum STPKs,
CgPknA and CgPknB, prior to the NMR structure determination.
An increased spectral dispersion due to important chemical shift
variations was observed on the [1H,15N] HSQC spectrum re-
corded after treatment with the kinases (Figures 5A and 5B).
As a first important result, frequency resonance sequential attri-
bution revealed a unique phosphorylation site on Thr15, easily
identified by the characteristic downfield chemical shift change
(Byeon et al., 2005) from Thr to pThr (2 ppm), and consistent
with our MS analysis (Figure 2). In addition, an important number570 Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All rights reserved
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Solution Structure of OdhIof intense peaks centered around 8.5 ppm in the 1H dimension of
the HSQC recorded on OdhI and attributed to mobile unfolded
residues disappeared in the HSQC spectrum recorded on
pOdhI. This suggests the structuring of a large part of the
N-terminal residues upon phosphorylation. This was further
confirmed by 15N heteronuclear NMR relaxation experiments
recorded on both isoforms of the protein. Although negative
[1H,15N] heteronuclear NOE values were observed in the
N-terminal segment (residues Met1 to Ala33) in the unphos-
phorylated form; positive values were observed around the puta-
tive phosphorylation site (residue Gln11 to Glu27) in the phos-
phorylated form of the protein (Figure 6). However, few
chemical shift variations were observed for residues belonging
to the FHA domain itself (Figures 5A and 5B), indicating that its
structure is globally preserved, even though some perturbations
are observed on the phosphothreonine binding site.
Structure calculation of the phosphorylated isoform of OdhI,
pOdhI, confirms that phosphorylation induces folding of the
N-terminal disordered region from residue Pro10 to Gly31 and
triggers the binding of the region surrounding pThr15 to the
FHA domain (Figures 4B–4D). More precisely, residues from
Ala20 to Ser29 fold into a short a-helix, and residues from
Val12 to Phe18 bind to the FHA phosphopeptide surface
between loop b4/b5 and b3/b4. This positioning is consistent
with the chemical shift perturbations observed on the pOdhI
HSQC spectrum and with what has been observed in the
previous structures of FHA domains in complex with phospho-
peptides. The phosphorylation-induced a-helix is markedly
Figure 3. OdhI NMR Fingerprint
[1H-15N] HSQC spectrum of OdhI from Coryne-
bacterium glutamicum recorded at 20C on a 15N
uniformly labeled sample. Cross-peak assign-
ments are indicated using the one-letter amino
acid and number. The central part of the spectrum
is expanded in the insert.
amphipathic with a hydrophobic surface
(Ala20, Leu22, Leu23, and Met26) facing
Tyr111 and Pro116 on the b7 and the b8
FHA strands, respectively. These hydro-
phobic contacts, conserved in GarA,
probably contribute to reinforce the
interaction between the phosphorylated
N-terminal peptides segment and the
FHA binding site.
It has been reported that the minimum
motif for recognition specificity is seven
residues centered on the phosphothreo-
nine (Durocher et al., 2000). Here, the
phosphorylation results in the folding of
26 amino acids from the N-terminal, but
only seven of them, centered on pThr15,
are in contact with the FHA core domain
according to our NMR data. The binding
surface and the contacts between the
phosphopeptide and its binding groove
are original with an unusual dual interac-
tion between the phosphate group and an arginine residue of
loop b4/b5, Arg87. Recently a similar interaction has been
described for the RNF8 FHA domain (Huen et al., 2007). The
characteristic interaction described between the FHA domain
and the phosphopeptide are conserved. The phosphate group
is making hydrogen bounds with the buried Ser86 and additional
hydrogen-bond interactions with main-chain atoms of residues
from the phosphopeptide on both sides of the phosphothreonine
are present. If not directly observable in our NMR experiments,
some interaction is likely to be present. For instance, Arg72 gua-
nidinium group from the Gly-Arg dipeptide motif, located at the
N-terminal side of the b3/b4 loop, is expected to be doubly
H-bonded to the phosphate group. In addition, the amide side
chain of the highly conserved asparagine Asn107 should make
hydrogen bonds with the main-chain carbonyl oxygen of the
pThr +1 residue and the peptide nitrogen of pThr +3.
Similarly, a-helix formation upon phosphorylation has been
previously reported for the hNIFK phosphopeptide after binding
to the Ki67 FHA domain (Byeon et al., 2005). Multiple phosphor-
ylations on this peptide and FHA domain binding are concomi-
tant with the formation of a 15 aa a-helix beginning four residues
after the first phosphorylated threonine. In our case, the a-helix
tops the b strands b7 and b8, whereas the hNIFK peptide a-helix
lies between loops b4/b5 and b10/b11with the C-terminal part of
the peptide forming an extra b strand antiparallel to b4.
The pOdhI structure clearly demonstrates an importantmolec-
ular switch governed by a single phosphorylation event in a disor-
dered domain.Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 571
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C D
Figure 4. Overall Structure of the OdhI Structures
(A) Cartoon representation of the OdhI unphosphorylated structure. The N-terminal part of the protein fromMet1 to Ala39 is fully disordered and not represented.
(B) Representation of the final ensemble comprising 30 NMR structures of the phosphorylated OdhI, pOdhI. The superimposition has been made on the core
domain backbone atoms. The residues Met1 to Glu9 are not represented as they remain fully disordered in both structures. The residues from Pro10 to
Ala39, unfolded in the unphosphorylated form, are represented wrapped around the FHA domain. The phosphothreonine anchoring in the FHA domain is rep-
resented in red, and the rest of the protein is in blue.
(C and D) Two views related by a 90 rotation along the z axis of a cartoon representation of the pOdhI structure. The residues Met1 to Glu9 are represented in
gray, Pro10 to Ala39 are in red; side chain atoms of the phosphothreonine anchoring in the FHA domain are also represented.DISCUSSION
In this study, the solution structure determinationofOdhI isoforms
revealed a major structural rearrangement in the phosphorylated
isoform, characterized by a tight self-recognition binding of the
phosphorylated N-terminal extension of the OdhI protein by the
C-terminal FHA domain. Because phosphorylation of OdhI leads
to a fully inactive protein unable to bind to OdhA, this intramolec-
ular change accounts for an autoinhibition mechanism that shuts
down the inhibition properties of OdhI (Figure 7). Morevover, an
autoinhibitionmechanismsimilar to theonedescribed in this study572 Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All righhas been recently reported for theM. tuberculosis OdhI homolog
GarA, using a physicochemical strategy (England et al., 2009).
However, it remains unclear whether it is the phosphorylation
and the binding of the N-terminal region that locks the FHA
domain of OdhI, or if the inhibition results from the N-terminal
part of OdhI becoming masked. The N-terminal sequence iden-
tity between the different species harboring OdhI/GarA ortho-
logues is relatively low compared with the FHA domain itself
(Figure 1). In addition, extensive sequence alignments of all the
members of the family revealed that more-distant OdhI/GarA
orthologs (sequence identity >60% for the FHA domain) lackts reserved
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Figure 5. Chemical Shift Perturbations following OdhI Phosphorylation
(A) [1H-15N] HSQC spectrum superimposition of OdhI nonphosphorylated (in black) with pOdhI phosphorylated by CgPknA/B (in red). Arrows connect resonances
for the residues 14–20 in their position prior to and after phosphorylation.
(B) Amide averaged chemical shift differences (Dd) as a function of the protein sequence. Dd have been calculated between the amide group resonances of OdhI
and pOdhI usingDd= [DdH
2+(DdN.gN/gH)
2]0,5. The inserted panel presents the Van derWaals diagram of theOdhI NMR structure, with a color gradient indicative of
the Dd value: from gray (Ddz0) to red (Ddmax for Thr15). Ellipses indicate the phosphothreonine site and the phosphopeptide binding site.the N-terminal part of the protein (data not shown). One possible
explanation could be that in these species the FHA domain
remains capable of inhibiting the TCA cycle, but may no longer
be controlled by STPK-dependent phosphorylation. Moreover,
considering the high value of the inhibitory constant (Ki = 2.4 nM
and IC50 = 4.3 nM; Niebisch et al., 2006), we propose that the
inhibition could be the result of the OdhI FHA domain binding
to OdhA. O’Hare et al. (2008) showed that a M. tuberculosis
GarA mutant with no phosphopeptide binding property in which
the crucial FHA residue Ser95 is substituted by Ala failed to
inhibit its target protein, KGD. This result clearly strengthens
our assumption that the unmasked FHA domain in OdhI is
required to promote binding to OdhA. However, the phosphory-
lation of OdhA remains to be established, as STPKs phosphory-
lation is a prerequisite for FHA recognition—even if preliminary
experiments in M. tuberculosis suggest that the recombinant
OdhA homolog expressed in E. coli (unlikely to be phosphory-
lated) is inhibited by GarA (O’Hare et al., 2008). Nevertheless, if
OdhA phosphorylation is confirmed, this mechanism of regula-
tion would lead to a double control on the OdhA enzyme activity
by STPKs. In other words, phosphorylation of the OdhA enzyme
would lead to its inhibition via binding with the unphosphorylated
OdhI isoform, and phosphorylation of OdhI would release that
inhibition on OdhA (Figure 7). Finally, an extensive analysis of
OdhA/KGD phosphorylation by different STPKs would be of
great interest to decipher the cross-talk networks used by the
bacterium to adapt its response to external stimuli correspond-
ing to environmental changes on the same metabolic pathway.Structure 17,Our study unambiguously determined Thr15 as the unique
phosphorylation site when OdhI is phosphorylated by CgPknA
or CgPknB, and this was further confirmed by mass spectrom-
etry and NMR analyses. It was previously reported that CgPknG
phosphorylates OdhI on Thr14 (Niebisch et al., 2006; Schultz
et al., 2007). This strongly confirms that phosphorylation is site
specific and dependent on the kinase, as already observed
with theM. tuberculosis homolog GarA. In fact, similar observa-
tions have been reported for GarA, for which Thr22was identified
following treatment with PknB (which corresponds to Thr15 in
OdhI, while Thr21 was the site identified following treatment
with PknG (which corresponds to Thr14 in OdhI; Figure 1). It is
noteworthy that multiple phosphorylation sites have been
described in eukaryotic phosphopeptide-binding FHA domains
(Byeon et al., 2005; Lee et al., 2008). For instance, double phos-
phorylation of the Rad53-SCD1 peptide increases affinity to the
Dun1-FHA domain by more than two orders of magnitude,
compared with a single phosphorylation. However, in that
case, multiple phosphorylation events occurred simultaneously
in Rad53-SCD1, whereas phosphorylation by either PknA/B or
PknG on GarA was mutually exclusive (O’Hare et al., 2008).
In M. tuberculosis it has been shown that phosphorylation on
both sites leads to the loss of the inhibition and binding proper-
ties (O’Hare et al., 2008). Sequences of the loop responsible for
the phosphopeptide recognition are strictly identical between
GarA and OdhI (Figure S2). Moreover, the N-terminal sequences
are strictly conserved between OdhI and GarA around the pThr
(position4 to +6), corresponding to a larger motif than the usual568–578, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 573
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Solution Structure of OdhIFigure 6. OdhI Isoforms Intrinsic Dynamics
15N{1H} NOEsmeasured at 20C for OdhI (open circles) and pOdhI (filled circles) as a function of the protein sequence. Protein domain delimitation and secondary
element assignment for the phosphorylated form of OdhI are represented on the top.residues described as essential for FHA binding (Durocher et al.,
2000). This indicates that the structural rearrangement observed
on pOdhI after phosphorylation by CgPknA/B on Thr15 should
be similar to the ones expected after phosphorylation on the
adjacent Thr14 position while phosphorylated with CgPknG,
and this in order to abolish the inhibition on OdhA. In fact, the
structure of pOdhI revealed that flexibility exists within the
N-terminal domain between residues Arg19 to Glu38 (Figure 6).
As a consequence, phosphorylation at position Thr14 could
lead to a similar molecular switch. A model of pOdhI phosphor-
ylated at position Thr14 reveals that the contact between the
FHA binding site and the phosphorylated N-terminal would be
possible with minor rearrangements of the phosphopeptide
binding loops. With phosphorylation at position Thr14 instead
of Thr15, the side chain of residue pThr +3 would be a valine
(Val17) instead of a phenylalanine (Phe18), making all the hydro-
phobic interactions observed around this position practical. It is
noteworthy that FHA domains are grouped into discrete classes
primarily on the basis of pThr +3 specificity (Yaffe and Smerdon,
2004). Similarly, a substitution at position pThr +2 from valine
(Val17) to serine (Ser16), and at position pThr +1 from serine
(Ser16) to threonine (Thr15), should be compatible with the574 Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All righbinding, as the interactionbetween thisphosphopeptidesegment
and the FHA binding region involves mainly backbone atoms. At
position pThr +1, the threonine (Thr14) would be substituted by
a glutamic acid (Glu13), but this substitution should not generate
any effect as the side chain is fully exposed to the solvent and
does not interact with the binding region. From our model, the
Glu13 Cb and Cgmethylene groups make hydrophobic contacts
with Val85 side chain; therefore, substituting Glu13 at position –2
with a valine residue (Val12) might increase the binding.
Despite our efforts, we never obtained an NMR sample of the
pOdhI protein phosphorylated at position Thr14 by CgPknG. This
is probably due to the high instability of CgPknG and the fact
that this protein needs to be phosphorylated by CgPknA/B to be
activated. The ability of the OdhI/GarA protein to be a common
substrate of two different kinases able to phosphorylate at two
adjacent positions, and thus resulting in a similar major structural
modification with the loss of inhibition properties, is remarkable
considering the high specificity of the FHA domain phosphopep-
tide binding site (Durocher et al., 2000; Yaffe and Smerdon, 2004).
Control of enzyme activity by phosphorylation has been re-
ported recently in actinomycetes (Bhatt et al., 2007), but to our
knowledge, the OdhA regulation by OdhI is the first reportedts reserved
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Solution Structure of OdhIFigure 7. Proposed Regulatory Role of the Different Isoforms of OdhI as a Molecular Switch in Regulation of the Krebs (TCA) Cycle
The OdhI protein is a Krebs cycle key regulator inC. glutamicum. The unphosphorylated form of OdhI inhibits the fourth step of the cycle, and the phosphorylated
form is inactive. Experimental evidence from NMR analysis unraveled a major conformational change between the two isoforms, leading to the binding of the
phosphorylated N-terminal part of the protein to its own FHA domain, consequently inhibiting it, thus corresponding to an autoinhibition mechanism.case of a bacterial enzyme controlled by phosphorylation via
a second partner. In M. tuberculosis, for instance, there is an
increasing number of processes found to be controlled by phos-
phorylation. Phosphorylation of the inhibitory protein (i.e., OdhI)
and its target protein (i.e., OdhA) by a different set of kinases
would allow bacteria to diversify and combine responses to
diverse external stimuli received by different STPKs. One can
also imagine that inhibitory protein (i.e., OdhI) could also recog-
nize and therefore regulate additional targets. With a relatively
restricted number of STPKs, the use of regulators like the OdhI/
GarA protein, common to multiple pathways, could represent
a way for the bacteria to extend its STPK regulation pathways.
Overall, our study describes for the first time a FHA domain
phosphorylation-dependent regulation that leads to a functional
alteration, and consequently to the inactivation, of its inhibitory
properties. The FHA domain is a structural domain widespread
inproteins involved inmajor eukaryotic cell processes.Moreover,
phosphorylation ofOdhI occurs in a complete disordered domain
and leads to the complete loss of its properties, which is similar to
eukaryotic proteins, as inhibition often involves phosphorylation
of an unfolded part of the protein. This original autoinhibitory
mechanism via a competitive intramolecular binding could be
compared with the one observed for the eukaryotic SH2 domain
protein (Kuriyan and Cowburn, 1997). Our findingsmay therefore
not be restricted to the exclusive prokaryotic FHA domain
proteins, but may represent a more general mechanism of post-
translational regulation. The unexpected role of OdhI/GarA as
a general molecular switch also emphasizes the fact that FHA
domains should not be considered as solely protein-protein
interaction domains but also as important activation/inhibition
modules participating in prokaryotic and eukaryotic signaling.
EXPERIMENTAL PROCEDURES
Expression and Purifications of the OdhI Protein
A 50 ml falcon tube containing 20 ml of L-broth (1% w/v tryptone, 0.5% w/v
NaCl, 0.5% w/v yeast extract) supplemented with 100 mg/ml of ampicillin
was inoculated with a single transformed bacterial colony of Escherichia coliStructure 17BL21(DE3)Star, harboring a variant of His-tag fusion vector pET-15b, which
was modified to contain the odhI gene from Corynebacterium glutamicum
and a tobacco etch virus (TEV) protease site to replace the thrombin site
coding sequence (named pET-15b-Tev). This culture was grown in an orbital
incubator set at 37C and 220 rpm overnight. From this culture, the 20 ml
was used to inoculate a 2-liter flask containing 750ml of L-broth supplemented
as before with ampicillin. The culture was grown in an orbital incubator set at
37C and 220 rpm, until the A600 of the culture reached 0.6, and then IPTG was
added at a final concentration of 0.2 mM to induce the expression of OdhI.
Growth of the cultures was continued for a further 3 hr at a lower temperature
of 30C, after which the cells were harvested by centrifugation (using a Beck-
man Coulter Avanti J-20 XP centrifuge equipped with a 10 500 rotor and set at
7C and 8000 rpm). The cell pellet arising from the 750ml of culture was resus-
pended, on ice, in 30 ml of buffer A (50 mM Tris-HCl [pH 8.5], 150 mM NaCl)
and 50 ml of 10 mg/ml lysozyme was added to aid in digestion of the cells.
Cell pellets were stored at 80C until required.
Cells were then lysed by sonication (2 s bursts for 5 min, at 60% amplitude,
with a large parallel probe; Vibra Cell 72405 (Bioblock Scientific, Illkirch,
France), after which cell debris and insoluble materials were removed by
centrifugation (using a Beckman Coulter Avanti J-20 XP centrifuge equipped
with a 25 50 rotor, set at 18,000 rpm, at 7C). The supernatant arising from
this step was filtered through a 0.22 mm PVDF filter (Millipore) and then loaded
through a AKTA basic system into a Hitrap 1ml IMACHP column (Amersham
Biosciences) equilibrated in buffer A and 4% of buffer B (50 ml of buffer A sup-
plemented with 500 mM of imidazole). Ni2+-agarose affinity chromatography
was then carried out at room temperature to purify the His-tagged recombi-
nant protein. The column was washed with successive applications of buffer
A and 4% of buffer B (30 ml in total) to remove all the impurities and then
buffer B was increased over 20 ml to 100%, which was collected in fractions
of 0.5 ml. Fractions containing the OdhI protein were identified by SDS-PAGE,
then pooled and concentrated, using a 5K cutoff concentrator, to a final volume
of 5 ml (using a Sigma Laborzentrifugen 3K15 bioblock scientific centrifuge set
at 7C, 4000 g). The concentrated protein was applied to a Hiprep 26/10
(Amersham Biosciences) desalting column equilibrated in buffer A, to remove
the imidazole, to increaseprotein stability. Thefirst two5ml fractions eluted cor-
responded to the protein and sowere pooled (total volume 10ml) and placed in
a labeled 15 ml falcon tube. The solution was treated for 2 hr at room tempera-
ture with TEV protease (1 OD of TEV for 100 OD of protein) to digest and
thereby remove the N-terminal His-tag from the protein.
Finally, the 10 ml of protein was concentrated (as before) to a final volume of
2 ml and applied to a Superdex 75 26/60 (Amersham Biosciences) size exclu-
sion column, equilibrated in buffer 20 mM Na phosphate (pH 6.2), 150 mM
NaCl. This led to the removal of any remaining impurities and the tag. Again,, 568–578, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 575
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pooled and stored at 20C until required.
This protocol was carried out for all nonlabeled constructs of OdhI and
15N-labeled OdhI constructs except the cultures, which were grown in
a minimum media containing 15NH4Cl and
13C6 glucose as the sole nitrogen
and carbon sources.
Expression and Purification of CgPknA and CgPknB
E. coli BL21(DE3)Star cells were transformed with the pGEX4T-3 vector deriv-
atives expressing the CgPknA and CgPknB core domain proteins (Fiuza et al.,
2008). Recombinant E. coli strains harboring the pGEX4T-3 derivatives were
used to inoculate 200ml of LBmedium supplemented with ampicillin and incu-
bated at 37Cwith shaking until A600 reached 0.5. Isopropyl 1-thio-b-D-galac-
topyranoside was then added at a final concentration of 0.5 mM, and growth
was continued for an additional 3 hr period at 30C. The cells were harvested
by centrifugation at 6000 g for 10 min, washed in 10 ml of buffer A (50 mM Tris-
HCl [pH 7.5], 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM aprotinin), and
centrifuged again under the same conditions. The cell pellet was resuspended
in buffer A containing DNase I and RNase A at a final concentration of 5 g/ml
each, 10 M leupeptin, and 6 M pepstatin.
Cells were disrupted in a French pressure cell at 16,000 lb/in2 (psi). The
resulting suspensionwas centrifuged at 4 C for 30min at 30,000 g. The superna-
tant was incubated for 5 hr with glutathione Sepharose 4B matrix (Pharmacia
Biotech), suitable for purification of GST fusion proteins. The protein-resin
complex was packed into a column for washing and elution. The column was
washed with 50 ml of PBS. Protein elution was carried out with buffer B
(50mMTris-HCl [pH8.0], 5mMMgCl2,1mMDTT)containing15mMglutathione.
Eluted fractions were analyzed by SDS-PAGE. After dialysis against buffer C
(40mMTris-HCl [pH 7.9], 200mMNaCl, 0.2 mMDTT, 0.2 mMEDTA, 10%glyc-
erol), pure fractionswerepooled.All proteinswerepurifiedunder thesamecondi-
tions, and their identity was checked by mass spectrometry (MALDI-TOF).
Phosphorylation of OdhI by CgPknA and CgPknB
In vitro phosphorylation of each recombinant OdhI sample (5 mg) was carried
out overnight at 37C in a reaction mixture containing buffer 25 mM Tris-HCl
(pH 7.0), 1 mM dithiothreitol, 5 mM MgCl2, 1 mM EDTA, and 5 mM ATP and
1 mg of kinases (CgPknA and CgPknB). The sample was then concentrated
and applied to a Superdex 75 10/30 (Amersham Biosciences) size exclusion
column, equilibrated in buffer 20 mM Na phosphate (pH 6.2), 150 mM NaCl.
Fractions containing the OdhI protein were identified by SDS-PAGE, then
pooled and stored and concentrated to a concentration of approximately
500 mM for NMR experiments.
Mass Spectrometry Analysis
Purified OdhI was subjected to in vitro phosphorylation as described. Subse-
quent mass spectrometry analyses were performed as previously described
(Fiuza et al., 2008).
Solution Structure of OdhI and pThr15-OdhI
All NMR experiments were carried out at 14.1 Tesla on a Bruker Avance 600
spectrometer equipped with 5 mm z-gradient 1H-13C-15N triple-resonance
cryoprobe. 1H, 13C, and 15N resonances were assigned using standard triple-
resonance 3D experiments (Sattler et al., 1999) recorded at 20C on 0.3 mM
15N- or 15N,13C-labeled OdhI protein samples dissolved in 20 mM sodium
phosphate (pH 6.2), 150 mMNaCl with 5%D2O for the lock.
1H chemical shifts
were directly referenced to the methyl resonance of DSS, whereas 13C and 15N
chemical shifts were referenced indirectly to the absolute frequency ratios
15N/1H = 0.101329118 and 13C/1H = 0.251449530. All NMR spectra were pro-
cessed with GIFA software (Pons et al., 1996). NOE peaks identified on 3D
[1H,15N] and [1H,13C] 3D NOESY-HSQC were assigned through automated
NMR structure calculations with CYANA 2.1 (Guntert, 2004).
Pulse sequences similar to those described (Kay et al., 1992; Peng and
Wagner, 1992a, 1992b) were used to record heteronuclear 15N{1H}NOE exper-
iments. The two experiments with andwithout proton saturationwere acquired
in an interleaved manner, FID by FID. Proton saturation was achieved by appli-
cation of high-power 120 pulse spaced at 20 ms intervals for 3 s prior to the576 Structure 17, 568–578, April 15, 2009 ª2009 Elsevier Ltd All rigfirst pulse on 15N. A relaxation delay equal to 6 s between each scan was used
to obtain a complete relaxation of water magnetization and to reduce effects
arising from amide proton exchange.
Backbone f and c torsion angle constraints were obtained from a database
search procedure on the basis of backbone (15N, HN, 13C’, 13Ca, Ha, 13Cb)
chemical shifts using the program TALOS (Cornilescu et al., 1999). Hydrogen
bond restraints were derived using standard criteria on the basis of the amide
1H / 2H exchange experiments and NOE data. When identified, the hydrogen
bond was enforced using the following restraints: ranges of 1.8–2.3 A˚ for
d(N-H,O), and 2.7–3.3 A˚ for d(N,O). The final list of restraints (from which
values redundant with the covalent geometry has been eliminated) consisted
of 290 intraresidues, 445 sequential, 63 medium-range (1 < i-j % 4), and 225
long-range upper-bound distance restraints, 156 backbone dihedral angle
restraints (f and 4), and 60 hydrogen bond restraints. The phosphothreonine
parameters were incorporated according the phosphorylated amino acid
library from Craft and Legge (2005). The 30 best structures (based on the final
target penalty function values) were minimized with CNS 1.2 according the
RECOORD procedure (Nederveen et al., 2005) and analyzed with PROCHECK
(Laskowski et al., 1993). The rms deviations were calculated with MOLMOL
(Koradi et al., 1996). Structural statistics are given as Supplemental Data
(Table 1).
Table 1. NMR and Refinement Statistics for Odhi Protein
Structures
OdhI pOdhI
NMR distance and dihedral constraints
Distance constraints
Total NOE 976 997
Intraresidue 269 279
Interresidue
Sequential (ji  jj = 1) 431 428
Medium-range (ji  jj < 4) 76 59
Long range (ji  jj > 5) 200 231
Intermolecular
Hydrogen bonds 60 60




Violations (mean and SD)
Max. dihedral angle violation () 3.33 ± 1.11 4.04 ± 1.05
Max. distance constraint violation (A˚) 0.16 ± 0.04 0.16 ± 0.04
Deviations from idealized geometry
Bond lengths (A˚) 0.012 ± 0.001 0.011 ± 0.001
Bond angles () 1.220 ± 0.031 1.199 ± 0.028
Impropers () 1.647 ± 0.101 1.572 ± 0.098
Ramachandran plot (%)
Most favored region 80.7 87.3
Additionally allowed region 17.2 11.8
Generously allowed region 1.6 0.5
Disallowed region 0.5 0.4
Average pairwise rmsda (A˚)
Backbone atoms 1.09 ± 0.23 0.74 ± 0.13
Heavy atoms 1.92 ± 0.24 1.45 ± 0.16
aPairwise rmsd was calculated among 30 refined structures for residues
48–71, 90–102, and 119–138.hts reserved
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Structure coordinates for OdhI and pOdhI have been deposited in the Protein
Data Bank (www.rcsb.org/pdb/) with entry codes 2kb4 and 2kb3. Chemical
shifts have been deposited in the BioMagResBank under accession numbers
BMRB-16039 and BMRB-16038.
SUPPLEMENTAL DATA
SupplementalData include threefiguresandcanbe foundwith this articleonline
at http://www.cell.com/structure/supplemental/S0969-2126-(09)00094-X.
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